| Study ID and year | Sample (M/F) | Diagnostic Standard | Intervention | Control | Course (Weeks) | Outcome measured | |||||||||||
| Faye et al. (2010) | 320 | 10 - 20 kg, MCP (2000 - 100,000 μL), Fever (≥37.5˚C) | Artesunate + Mefloquine (AS + MQ) | Arthemether-Lumefantrine (AL) | 4 | Malaria treatment | |||||||||||
| Kapisi et al. (2015) | 3113 (1723/1370) | Blood conformation of Parasitaemia | No Chemoprevention | Monthly Sylphadoxine- Pyrimethamine (SP) | Daily trimethoprim- Sulphamethoxazole (TS) | Monthly Dihydroartemisinin- Piperaquine (DHAPQ) | 4 | Malaria treatment | |||||||||
| Maiga et al. (2015) | 912 (470/442) | ˃5 kg, MCP (2000 - 100,000 μL), Fever (≥37.5˚C), Hb (7.0 g/dl) | Sulphadoxine-Pyrimethamine + Artesunate (SP+AS) | Sulphadoxine-Pyrimethamine + Amodiaquine (SP + AQ) | Sulphadoxine-Pyrimethamine (SP) Monotherapy | 4 | Malaria treatment | ||||||||||
| Nambozi et al. (2011) | 304 (176/128) | ˃5 kg, MCP (2000 - 200,000 μL), Fever (≥37.5˚C) | Dihydroartemisinin-Piperaquine (DHAPQ) | Arthemether-Lumefantrine (AL) | 6 | Malaria treatment | |||||||||||
| Schramm et al. (2013) | 299 (177/122) | MCP (2000 - 100,000 μL), Fever (≥37.5˚C) | Artesunate + Amodiaquine (AS + AQ) | Arthemether-Lumefantrine (AL) | 6 | Malaria treatment | |||||||||||
| The 4ABC study Group (2011) | 4116 (2179/1897) | ˃5 kg, MCP (2000 - 100,000 μL), Fever (≥37.5˚C), Hb (7.0 g/dl) | Artesunate + Amodiaquine (AS + AQ) | Dihydroartemisinin- Piperaquine (DHAPQ) | Chlorproguanil-dapsone + Artesunate (CD + A) | 4 | Malaria treatment | ||||||||||
| Whegang et al. (2010) | 1401 | ˃5 kg, MCP (2000 - 100,000 μL), Fever (≥37.5˚C) | Amodiaquine Monotherapy (AQ) | Artesunate amodiaquine (AS + AQ) | Sulphadoxine-Pyrimethamine (SP) | Sulphadoxine-Pyrimethamine + Amodiaquine (SP+AQ) | Chlorproguanil-dapsone +Artesunate (CD + A) | Artesunate- mefloquine (AS-MQ | Artemether- lumefantrine (AL) | Dihydroartemisinin-piperaquine (DHAPQ) | 4 | Malaria treatment | |||||
| Yeka et al. (2013) | 218 (127/91) | ˃5 kg, MCP (2000-100,000 μL), Fever (≥37.5˚C) | Quinine (Q) | Arthemether-Lumefantrine (AL) | 4 | Malaria treatment | |||||||||||